Novo Buys Three Plants for $11 Billion to Boost Wegovy Output
(Bloomberg) — Novo Nordisk A/S agreed to buy three manufacturing plants for $11 billion to help it meet surging demand for the obesity drug Wegovy and diabetes shot…
Read more Novo Buys Three Plants for $11 Billion to Boost Wegovy Output